Vascular Biogenics Ltd (VBLT)

[davidal66]

Yes, on point two this is correct. I know the rGBM patient/family community is quite enthusiastic about VB-111 as are neurosurgeons. Added to that, there is not a compelling phase III trial out there outside of the polio Duke trial(s)--but the Duke trials have substantial restrictions about tumor location while VB-111 allows pretty much all rGBM so it's much more accessible. It, the phase III, is picking up steam in enrollment.